Submitted by Anonymous (not verified) on 2 August 2023 - 7:30
Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Arthroplasty, Replacement;Venous Thromboembolism, Date of authorisation: 30/09/2008, Revision: 40, Status: Authorised
Source: